 | • レポートコード：MRC2-11QY11193 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は乳癌スクリーニング検査のグローバル市場について調査・分析したレポートです。種類別（身体検査、実験室検査、画像検査、遺伝子検査）市場規模、用途別（研究所、癌研究所、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別乳癌スクリーニング検査の競争状況、市場シェア ・世界の乳癌スクリーニング検査市場：種類別市場規模 2015年-2020年（身体検査、実験室検査、画像検査、遺伝子検査） ・世界の乳癌スクリーニング検査市場：種類別市場規模予測 2021年-2026年（身体検査、実験室検査、画像検査、遺伝子検査） ・世界の乳癌スクリーニング検査市場：用途別市場規模 2015年-2020年（研究所、癌研究所、診断センター、その他） ・世界の乳癌スクリーニング検査市場：用途別市場規模予測 2021年-2026年（研究所、癌研究所、診断センター、その他） ・北米の乳癌スクリーニング検査市場分析：米国、カナダ ・ヨーロッパの乳癌スクリーニング検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの乳癌スクリーニング検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の乳癌スクリーニング検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの乳癌スクリーニング検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Hologic、Siemens Healthcare、Carestream Health、Philips Healthcare、Shimadzu Corporation、Canon Medical Systems、Hitachi Medical Corporation、Esaote、Agilent Technologies ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the signs & symptoms of breast cancer. Breast cancer screening does not prevent the disease. However, detection in early stage increases the chances of recovery from the disease. Breast cancer screening tests are offered to women aged between 50-70 years as they are more prone to the disease.
Breast Cancer Screening Tests Market is primarily driven by a few key factors such as the patient awareness regarding rising healthcare concerns, increasing research for detection of various types of cancers, and prevention of disease. In addition to this, Breast Cancer Screening Tests Market also observes significant growth due to different government initiatives and public awareness campaigns.
Market Analysis and Insights: Global Breast Cancer Screening Tests Market
The global Breast Cancer Screening Tests market size is projected to reach US$ 1255.5 million by 2026, from US$ 1194 million in 2020, at a CAGR of 4.8%% during 2021-2026.
Global Breast Cancer Screening Tests Scope and Market Size
Breast Cancer Screening Tests market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Screening Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Hologic
Siemens Healthcare
Carestream Health
Philips Healthcare
Shimadzu Corporation
Canon Medical Systems
Hitachi Medical Corporation
Esaote
Agilent Technologies
Market segment by Type, the product can be split into
Physical Exam
Laboratory Tests
Imaging Tests
Genetic Tests
Market segment by Application, split into
Research Labs
Cancer Institutes
Diagnostic Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Breast Cancer Screening Tests Revenue
1.4 Market by Type
1.4.1 Global Breast Cancer Screening Tests Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Physical Exam
1.4.3 Laboratory Tests
1.4.4 Imaging Tests
1.4.5 Genetic Tests
1.5 Market by Application
1.5.1 Global Breast Cancer Screening Tests Market Share by Application: 2020 VS 2026
1.5.2 Research Labs
1.5.3 Cancer Institutes
1.5.4 Diagnostic Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Screening Tests Market Perspective (2015-2026)
2.2 Global Breast Cancer Screening Tests Growth Trends by Regions
2.2.1 Breast Cancer Screening Tests Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Breast Cancer Screening Tests Historic Market Share by Regions (2015-2020)
2.2.3 Breast Cancer Screening Tests Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Breast Cancer Screening Tests Market Growth Strategy
2.3.6 Primary Interviews with Key Breast Cancer Screening Tests Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Screening Tests Players by Market Size
3.1.1 Global Top Breast Cancer Screening Tests Players by Revenue (2015-2020)
3.1.2 Global Breast Cancer Screening Tests Revenue Market Share by Players (2015-2020)
3.1.3 Global Breast Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Breast Cancer Screening Tests Market Concentration Ratio
3.2.1 Global Breast Cancer Screening Tests Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Breast Cancer Screening Tests Revenue in 2019
3.3 Breast Cancer Screening Tests Key Players Head office and Area Served
3.4 Key Players Breast Cancer Screening Tests Product Solution and Service
3.5 Date of Enter into Breast Cancer Screening Tests Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Breast Cancer Screening Tests Historic Market Size by Type (2015-2020)
4.2 Global Breast Cancer Screening Tests Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Breast Cancer Screening Tests Market Size by Application (2015-2020)
5.2 Global Breast Cancer Screening Tests Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Breast Cancer Screening Tests Market Size (2015-2020)
6.2 Breast Cancer Screening Tests Key Players in North America (2019-2020)
6.3 North America Breast Cancer Screening Tests Market Size by Type (2015-2020)
6.4 North America Breast Cancer Screening Tests Market Size by Application (2015-2020)
7 Europe
7.1 Europe Breast Cancer Screening Tests Market Size (2015-2020)
7.2 Breast Cancer Screening Tests Key Players in Europe (2019-2020)
7.3 Europe Breast Cancer Screening Tests Market Size by Type (2015-2020)
7.4 Europe Breast Cancer Screening Tests Market Size by Application (2015-2020)
8 China
8.1 China Breast Cancer Screening Tests Market Size (2015-2020)
8.2 Breast Cancer Screening Tests Key Players in China (2019-2020)
8.3 China Breast Cancer Screening Tests Market Size by Type (2015-2020)
8.4 China Breast Cancer Screening Tests Market Size by Application (2015-2020)
9 Japan
9.1 Japan Breast Cancer Screening Tests Market Size (2015-2020)
9.2 Breast Cancer Screening Tests Key Players in Japan (2019-2020)
9.3 Japan Breast Cancer Screening Tests Market Size by Type (2015-2020)
9.4 Japan Breast Cancer Screening Tests Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Breast Cancer Screening Tests Market Size (2015-2020)
10.2 Breast Cancer Screening Tests Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Breast Cancer Screening Tests Market Size by Type (2015-2020)
10.4 Southeast Asia Breast Cancer Screening Tests Market Size by Application (2015-2020)
11 India
11.1 India Breast Cancer Screening Tests Market Size (2015-2020)
11.2 Breast Cancer Screening Tests Key Players in India (2019-2020)
11.3 India Breast Cancer Screening Tests Market Size by Type (2015-2020)
11.4 India Breast Cancer Screening Tests Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Breast Cancer Screening Tests Market Size (2015-2020)
12.2 Breast Cancer Screening Tests Key Players in Central & South America (2019-2020)
12.3 Central & South America Breast Cancer Screening Tests Market Size by Type (2015-2020)
12.4 Central & South America Breast Cancer Screening Tests Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Hologic
13.1.1 Hologic Company Details
13.1.2 Hologic Business Overview
13.1.3 Hologic Breast Cancer Screening Tests Introduction
13.1.4 Hologic Revenue in Breast Cancer Screening Tests Business (2015-2020))
13.1.5 Hologic Recent Development
13.2 Siemens Healthcare
13.2.1 Siemens Healthcare Company Details
13.2.2 Siemens Healthcare Business Overview
13.2.3 Siemens Healthcare Breast Cancer Screening Tests Introduction
13.2.4 Siemens Healthcare Revenue in Breast Cancer Screening Tests Business (2015-2020)
13.2.5 Siemens Healthcare Recent Development
13.3 Carestream Health
13.3.1 Carestream Health Company Details
13.3.2 Carestream Health Business Overview
13.3.3 Carestream Health Breast Cancer Screening Tests Introduction
13.3.4 Carestream Health Revenue in Breast Cancer Screening Tests Business (2015-2020)
13.3.5 Carestream Health Recent Development
13.4 Philips Healthcare
13.4.1 Philips Healthcare Company Details
13.4.2 Philips Healthcare Business Overview
13.4.3 Philips Healthcare Breast Cancer Screening Tests Introduction
13.4.4 Philips Healthcare Revenue in Breast Cancer Screening Tests Business (2015-2020)
13.4.5 Philips Healthcare Recent Development
13.5 Shimadzu Corporation
13.5.1 Shimadzu Corporation Company Details
13.5.2 Shimadzu Corporation Business Overview
13.5.3 Shimadzu Corporation Breast Cancer Screening Tests Introduction
13.5.4 Shimadzu Corporation Revenue in Breast Cancer Screening Tests Business (2015-2020)
13.5.5 Shimadzu Corporation Recent Development
13.6 Canon Medical Systems
13.6.1 Canon Medical Systems Company Details
13.6.2 Canon Medical Systems Business Overview
13.6.3 Canon Medical Systems Breast Cancer Screening Tests Introduction
13.6.4 Canon Medical Systems Revenue in Breast Cancer Screening Tests Business (2015-2020)
13.6.5 Canon Medical Systems Recent Development
13.7 Hitachi Medical Corporation
13.7.1 Hitachi Medical Corporation Company Details
13.7.2 Hitachi Medical Corporation Business Overview
13.7.3 Hitachi Medical Corporation Breast Cancer Screening Tests Introduction
13.7.4 Hitachi Medical Corporation Revenue in Breast Cancer Screening Tests Business (2015-2020)
13.7.5 Hitachi Medical Corporation Recent Development
13.8 Esaote
13.8.1 Esaote Company Details
13.8.2 Esaote Business Overview
13.8.3 Esaote Breast Cancer Screening Tests Introduction
13.8.4 Esaote Revenue in Breast Cancer Screening Tests Business (2015-2020)
13.8.5 Esaote Recent Development
13.9 Agilent Technologies
13.9.1 Agilent Technologies Company Details
13.9.2 Agilent Technologies Business Overview
13.9.3 Agilent Technologies Breast Cancer Screening Tests Introduction
13.9.4 Agilent Technologies Revenue in Breast Cancer Screening Tests Business (2015-2020)
13.9.5 Agilent Technologies Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Breast Cancer Screening Tests Key Market Segments
Table 2. Key Players Covered: Ranking by Breast Cancer Screening Tests Revenue
Table 3. Ranking of Global Top Breast Cancer Screening Tests Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Breast Cancer Screening Tests Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Physical Exam
Table 6. Key Players of Laboratory Tests
Table 7. Key Players of Imaging Tests
Table 8. Key Players of Genetic Tests
Table 9. Global Breast Cancer Screening Tests Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Breast Cancer Screening Tests Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Breast Cancer Screening Tests Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Breast Cancer Screening Tests Market Share by Regions (2015-2020)
Table 13. Global Breast Cancer Screening Tests Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Breast Cancer Screening Tests Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Breast Cancer Screening Tests Market Growth Strategy
Table 19. Main Points Interviewed from Key Breast Cancer Screening Tests Players
Table 20. Global Breast Cancer Screening Tests Revenue by Players (2015-2020) (Million US$)
Table 21. Global Breast Cancer Screening Tests Market Share by Players (2015-2020)
Table 22. Global Top Breast Cancer Screening Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Screening Tests as of 2019)
Table 23. Global Breast Cancer Screening Tests by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Breast Cancer Screening Tests Product Solution and Service
Table 26. Date of Enter into Breast Cancer Screening Tests Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Breast Cancer Screening Tests Market Size by Type (2015-2020) (Million US$)
Table 29. Global Breast Cancer Screening Tests Market Size Share by Type (2015-2020)
Table 30. Global Breast Cancer Screening Tests Revenue Market Share by Type (2021-2026)
Table 31. Global Breast Cancer Screening Tests Market Size Share by Application (2015-2020)
Table 32. Global Breast Cancer Screening Tests Market Size by Application (2015-2020) (Million US$)
Table 33. Global Breast Cancer Screening Tests Market Size Share by Application (2021-2026)
Table 34. North America Key Players Breast Cancer Screening Tests Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Breast Cancer Screening Tests Market Share (2019-2020)
Table 36. North America Breast Cancer Screening Tests Market Size by Type (2015-2020) (Million US$)
Table 37. North America Breast Cancer Screening Tests Market Share by Type (2015-2020)
Table 38. North America Breast Cancer Screening Tests Market Size by Application (2015-2020) (Million US$)
Table 39. North America Breast Cancer Screening Tests Market Share by Application (2015-2020)
Table 40. Europe Key Players Breast Cancer Screening Tests Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Breast Cancer Screening Tests Market Share (2019-2020)
Table 42. Europe Breast Cancer Screening Tests Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Breast Cancer Screening Tests Market Share by Type (2015-2020)
Table 44. Europe Breast Cancer Screening Tests Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Breast Cancer Screening Tests Market Share by Application (2015-2020)
Table 46. China Key Players Breast Cancer Screening Tests Revenue (2019-2020) (Million US$)
Table 47. China Key Players Breast Cancer Screening Tests Market Share (2019-2020)
Table 48. China Breast Cancer Screening Tests Market Size by Type (2015-2020) (Million US$)
Table 49. China Breast Cancer Screening Tests Market Share by Type (2015-2020)
Table 50. China Breast Cancer Screening Tests Market Size by Application (2015-2020) (Million US$)
Table 51. China Breast Cancer Screening Tests Market Share by Application (2015-2020)
Table 52. Japan Key Players Breast Cancer Screening Tests Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Breast Cancer Screening Tests Market Share (2019-2020)
Table 54. Japan Breast Cancer Screening Tests Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Breast Cancer Screening Tests Market Share by Type (2015-2020)
Table 56. Japan Breast Cancer Screening Tests Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Breast Cancer Screening Tests Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Breast Cancer Screening Tests Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Breast Cancer Screening Tests Market Share (2019-2020)
Table 60. Southeast Asia Breast Cancer Screening Tests Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Breast Cancer Screening Tests Market Share by Type (2015-2020)
Table 62. Southeast Asia Breast Cancer Screening Tests Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Breast Cancer Screening Tests Market Share by Application (2015-2020)
Table 64. India Key Players Breast Cancer Screening Tests Revenue (2019-2020) (Million US$)
Table 65. India Key Players Breast Cancer Screening Tests Market Share (2019-2020)
Table 66. India Breast Cancer Screening Tests Market Size by Type (2015-2020) (Million US$)
Table 67. India Breast Cancer Screening Tests Market Share by Type (2015-2020)
Table 68. India Breast Cancer Screening Tests Market Size by Application (2015-2020) (Million US$)
Table 69. India Breast Cancer Screening Tests Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Breast Cancer Screening Tests Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Breast Cancer Screening Tests Market Share (2019-2020)
Table 72. Central & South America Breast Cancer Screening Tests Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Breast Cancer Screening Tests Market Share by Type (2015-2020)
Table 74. Central & South America Breast Cancer Screening Tests Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Breast Cancer Screening Tests Market Share by Application (2015-2020)
Table 76. Hologic Company Details
Table 77. Hologic Business Overview
Table 78. Hologic Product
Table 79. Hologic Revenue in Breast Cancer Screening Tests Business (2015-2020) (Million US$)
Table 80. Hologic Recent Development
Table 81. Siemens Healthcare Company Details
Table 82. Siemens Healthcare Business Overview
Table 83. Siemens Healthcare Product
Table 84. Siemens Healthcare Revenue in Breast Cancer Screening Tests Business (2015-2020) (Million US$)
Table 85. Siemens Healthcare Recent Development
Table 86. Carestream Health Company Details
Table 87. Carestream Health Business Overview
Table 88. Carestream Health Product
Table 89. Carestream Health Revenue in Breast Cancer Screening Tests Business (2015-2020) (Million US$)
Table 90. Carestream Health Recent Development
Table 91. Philips Healthcare Company Details
Table 92. Philips Healthcare Business Overview
Table 93. Philips Healthcare Product
Table 94. Philips Healthcare Revenue in Breast Cancer Screening Tests Business (2015-2020) (Million US$)
Table 95. Philips Healthcare Recent Development
Table 96. Shimadzu Corporation Company Details
Table 97. Shimadzu Corporation Business Overview
Table 98. Shimadzu Corporation Product
Table 99. Shimadzu Corporation Revenue in Breast Cancer Screening Tests Business (2015-2020) (Million US$)
Table 100. Shimadzu Corporation Recent Development
Table 101. Canon Medical Systems Company Details
Table 102. Canon Medical Systems Business Overview
Table 103. Canon Medical Systems Product
Table 104. Canon Medical Systems Revenue in Breast Cancer Screening Tests Business (2015-2020) (Million US$)
Table 105. Canon Medical Systems Recent Development
Table 106. Hitachi Medical Corporation Company Details
Table 107. Hitachi Medical Corporation Business Overview
Table 108. Hitachi Medical Corporation Product
Table 109. Hitachi Medical Corporation Revenue in Breast Cancer Screening Tests Business (2015-2020) (Million US$)
Table 110. Hitachi Medical Corporation Recent Development
Table 111. Esaote Business Overview
Table 112. Esaote Product
Table 113. Esaote Company Details
Table 114. Esaote Revenue in Breast Cancer Screening Tests Business (2015-2020) (Million US$)
Table 115. Esaote Recent Development
Table 116. Agilent Technologies Company Details
Table 117. Agilent Technologies Business Overview
Table 118. Agilent Technologies Product
Table 119. Agilent Technologies Revenue in Breast Cancer Screening Tests Business (2015-2020) (Million US$)
Table 120. Agilent Technologies Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Screening Tests Market Share by Type: 2020 VS 2026
Figure 2. Physical Exam Features
Figure 3. Laboratory Tests Features
Figure 4. Imaging Tests Features
Figure 5. Genetic Tests Features
Figure 6. Global Breast Cancer Screening Tests Market Share by Application: 2020 VS 2026
Figure 7. Research Labs Case Studies
Figure 8. Cancer Institutes Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Breast Cancer Screening Tests Report Years Considered
Figure 12. Global Breast Cancer Screening Tests Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Breast Cancer Screening Tests Market Share by Regions: 2020 VS 2026
Figure 14. Global Breast Cancer Screening Tests Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Breast Cancer Screening Tests Market Share by Players in 2019
Figure 17. Global Top Breast Cancer Screening Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Screening Tests as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Breast Cancer Screening Tests Revenue in 2019
Figure 19. North America Breast Cancer Screening Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Breast Cancer Screening Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Breast Cancer Screening Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Breast Cancer Screening Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Breast Cancer Screening Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Breast Cancer Screening Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Breast Cancer Screening Tests Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
前立腺がんスクリーニングの世界市場（～2026年） Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms. The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measu…- 肺がん診断検査の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Diagnostic Tests Market The global Lung Cancer Diagnostic Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lung Cancer Diagnostic Tests Scope and Market Size Lung C…
- 子宮頸がんスクリーニングの世界市場（～2026年） Cervical screening is the process of recognizing and expelling abnormal tissue or cells in the cervix before precancerous cervical lesions or cervical malignancy develops. Continuous growth of cancer‘s impact on Public Health is the primary factor that drives the Cervical Cancer Screening Market. Th…
- 自己免疫疾患用体外診断（IVD）・ラボ開発検査の世界市場（～2026年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…
- E型肝炎診断検査の世界市場（～2026年） Hepatitis E is a virus that affects your liver. Market Analysis and Insights: Global Hepatitis E Diagnostic Tests Market The global Hepatitis E Diagnostic Tests market size is projected to reach US$ 43 million by 2026, from US$ 42 million in 2020, at a CAGR of 2.2%% during 2021-2026. Global Hepatiti…